Press Releases (Sputnik v)
-
-
Governor Tamilisai reviews Sputnik-V and 2DG anti-Covid drug manufacturing
-
Dr. Reddy’s receives approval to conduct Phase 3 clinical trial for Sputnik V vaccine in India
-
Sputnik V meets the primary endpoint of safety in the Phase 2 Clinical Trial in India
-
Dr. Reddy's and RDIF commence clinical trials for Sputnik V vaccine in India
-
RDIF and Hetero agree to produce over 100 million doses of the Sputnik V vaccine in India
-
Dr. Reddy’s and RDIF receive approval to conduct clinical trial for Sputnik V vaccine in India